Expert Answered Reta solution for Hypothyroidism

Back Reta solution for Hypothyroidism
Retatrutide, Tirzepatide and Semaglutide: dosing, fat loss, side effects, switching between compounds.

Shiko48

Newbie
Joined
Dec 9, 2025
Messages
2
Reaction score
4
Points
3.00
I have a friend who would like to try Retatrutide. However, she has hypothyroidism (an underactive thyroid).

Her primary care physician has advised her against taking Semaglutide or Tirzepatide because of her thyroid condition.

Since primary care physicians are often quite skeptical about peptides and tend to advise against them in general, I'm wondering whether his concerns are actually medically justified in this case.

Is he right to warn her against using these substances, or does hypothyroidism not really play a significant role when it comes to Retatrutide, Semaglutide, or Tirzepatide?

She is 50 years old, 1.74 m tall, and currently weighs 88.4 kg. Due to a thyroid disorder, she takes 175 µg of L-Thyroxin beta, which contains the active ingredient levothyroxine. This medication is used for thyroid hormone replacement therapy.

Does anyone have personal experience with this or a deeper understanding of the medical side of things?

Thanks in advance for your input!
 
Last edited:
Hi.

Hypothyroidism itself isn't listed as a contraindication for semaglutide/tirzepatide. The boxed warning concerns medullary thyroid carcinoma and MEN2 (personal or family history) which is a fairly rare cancer. Worth asking her if she had this in mind, or whether it was something else in her medical history.

The main concern I would have would be the effect of losing weight too abruptly on thyroid function. This may require a reassessment of the thyroid treatment dose during the weight loss phase. Therefore, strict monitoring is needed.

The other relevant issue with levothyroxine + GLP1 is that these drugs slow gastric emptying, which may change absorption. Evidence is limited (small studies, case reports), but it's a reason for TSH follow-up during treatment.

Retatrutide is still investigational (Phase 3, no approval yet), so there's no label and no regulated supply outside trials.

So maybe start with tirzepatide first to be "safe".
 
Upvote 0
Back
Top